These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 18855601)

  • 21. Solid-state characterization of nifedipine solid dispersions.
    Vippagunta SR; Maul KA; Tallavajhala S; Grant DJ
    Int J Pharm; 2002 Apr; 236(1-2):111-23. PubMed ID: 11891075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Multi-unit controlled release systems of nifedipine and nifedipine:pluronic F-68 solid dispersions: characterization of release mechanisms.
    Mehta KA; Kislalioglu MS; Phuapradit W; Malick AW; Shah NH
    Drug Dev Ind Pharm; 2002 Mar; 28(3):275-85. PubMed ID: 12026220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of Dissolution Medium pH and Simulated Gastrointestinal Contraction on Drug Release From Nifedipine Extended-Release Tablets.
    Gao Z; Ngo C; Ye W; Rodriguez JD; Keire D; Sun D; Wen H; Jiang W
    J Pharm Sci; 2019 Mar; 108(3):1189-1194. PubMed ID: 30343136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Investigations on the drug releasing mechanism from an asymmetric membrane-coated capsule with an in situ formed delivery orifice.
    Lin YK; Ho HO
    J Control Release; 2003 Apr; 89(1):57-69. PubMed ID: 12695063
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preparation and characterisation of Kolliphor® P 188 and P 237 solid dispersion oral tablets containing the poorly water soluble drug disulfiram.
    Ramadhani N; Shabir M; McConville C
    Int J Pharm; 2014 Nov; 475(1-2):514-22. PubMed ID: 25218186
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Monolithic osmotic tablet containing solid dispersion of 10-hydroxycamptothecin.
    Chen H; Jiang G; Ding F
    Drug Dev Ind Pharm; 2009 Feb; 35(2):131-7. PubMed ID: 19169941
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Development of an osmotic pump system for controlled delivery of diclofenac sodium.
    Emara LH; Taha NF; Badr RM; Mursi NM
    Drug Discov Ther; 2012 Oct; 6(5):269-77. PubMed ID: 23229148
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The effect of pore-formers and plasticizers on the release kinetic of diltiazem hydrochloride from the controlled porosity osmotic pumps.
    Shokri J; H Zarrintan M; Ghanbarzadeh S; Arash Z; Farahani A; Adibkia K
    Drug Res (Stuttg); 2013 Aug; 63(8):414-9. PubMed ID: 23599037
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Synthesis and characterization of osmotic pump capsules containing polyoxyethylene and pH modifier to control the release of nifedipine.
    Yu J; Meng X; Dong X; Han M; Li G; Chen Y; Liu Y; Hu L
    Eur J Pharm Biopharm; 2021 Jun; 163():102-108. PubMed ID: 33819628
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Solid state and dissolution rate characterization of co-ground mixtures of nifedipine and hydrophilic carriers.
    Friedrich H; Nada A; Bodmeier R
    Drug Dev Ind Pharm; 2005 Sep; 31(8):719-28. PubMed ID: 16221606
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of monolithic osmotic tablet system for nifedipine delivery in vitro and in vivo.
    Liu X; Chen D; Zhang R
    Drug Dev Ind Pharm; 2003 Aug; 29(7):813-9. PubMed ID: 12906339
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: stability testing of selected solid dispersions.
    Ghebremeskel AN; Vemavarapu C; Lodaya M
    Pharm Res; 2006 Aug; 23(8):1928-36. PubMed ID: 16871443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Spray-dried solid dispersions of nifedipine and vinylcaprolactam/vinylacetate/PEG₆₀₀₀ for compacted oral formulations.
    Soulairol I; Tarlier N; Bataille B; Cacciaguerra T; Sharkawi T
    Int J Pharm; 2015 Mar; 481(1-2):140-7. PubMed ID: 25579869
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Push-pull osmotic pump for zero order delivery of lithium carbonate: development and in vitro characterization.
    Patel V; Chudasama A; Nivsarkar M; Vasu K; Shishoo C
    Pharm Dev Technol; 2012; 17(3):375-82. PubMed ID: 21284541
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
    Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
    Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Novel osmotic pump tablet using core of drug-resin complexes for time-controlled delivery system.
    Wang C; Chen F; Li JZ; Tang H; Li X; Yan KS; Ye GH; Pan WS
    Yakugaku Zasshi; 2008 May; 128(5):773-82. PubMed ID: 18451626
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Development, evaluation, and influence of formulation and process variables on
    Arjun N; Narendar D; Sunitha K; Harika K; Nagaraj B
    Int J Pharm Investig; 2016; 6(4):238-246. PubMed ID: 28123994
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nifedipine di-matrix depot tablets prepared by compression coating for obtaining zero-order release.
    Liu T; Shi Y; Li J; Jiang W; Yin T; Zhang Y; He H; Wang Y; Tang X
    Drug Dev Ind Pharm; 2018 Sep; 44(9):1426-1433. PubMed ID: 29871528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Design of salbutamol EOP tablets from pharmacokinetics parameters.
    Sinchaipanid N; Pongwai S; Limsuwan P; Mitrevej A
    Pharm Dev Technol; 2003; 8(2):135-42. PubMed ID: 12760564
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15.
    Rajebahadur M; Zia H; Nues A; Lee C
    Drug Deliv; 2006; 13(3):201-6. PubMed ID: 16556572
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.